Effects of methyl p-hydroxybenzoate (methyl paraben) on Ca 2+ concentration and histamine release in rat peritoneal mast cells

Sanae Fukugasako, Shinichi Ito, Yoshimi Ikemoto

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

1. Mechanisms of methyl p-hydroxybenzoate (methyl paraben) action in allergic reactions were investigated by measuring the intracellular Ca 2+ concentration ([Ca 2+] i) and histamine release in rat peritoneal mast cells (RPMCs). 2. In the presence or absence of extracellular Ca 2+, methyl paraben (0.1-10 mM) increased [Ca 2+] i, in a concentration-dependent manner. Under both the conditions, methyl paraben alone did not evoke histamine release. 3. In RPMCs pretreated with a protein kinase C (PKC) activator (phorbol 12-myristate 13-acetate (PMA) 3 and 10 nM), methyl paraben (0.3-3 mM) induced histamine release. However, a high concentration (10 mM) of the agent did not increase the histamine release. 4. U73122 (0.1 and 0.5 μM), an inhibitor of phospholipase C (PLC), significantly inhibited the methyl paraben-induced histamine release in PMA-pretreated RPMCs. U73343 (0.5 μM), an inactive analogue of U73122, did not inhibit the histamine release caused by methyl paraben. 5. In Ca 2+-free solution, PLC inhibitors (U73122 0.1 and 0.5 μM, D609 1-10 μM) inhibited the methyl paraben-induced increase in [Ca 2+] i, whereas U73343 (0.5 μM) did not. 6. Xestospongin C (2-20 μM) and 2 aminoethoxydiphenyl borate (30 and 100 μM), blockers of the inositol 1,4,5-trisphosphate (IP 3) receptor, inhibited the methyl paraben-induced increase in [Ca 2+] i in Ca 2+-free solution. 7. In conclusion, methyl paraben causes an increase in [Ca 2+] i, which may be due to release of Ca 2+ from storage sites by IP 3 via activation of PLC in RPMCs. In addition, methyl paraben possibly has some inhibitory effects on histamine release via unknown mechanisms.

Original languageEnglish
Pages (from-to)381-387
Number of pages7
JournalBritish Journal of Pharmacology
Volume139
Issue number2
DOIs
Publication statusPublished - May 2003

Fingerprint

Parabens
Histamine Release
Mast Cells
Type C Phospholipases
Acetates
methylparaben
Inositol 1,4,5-Trisphosphate
Protein Kinase C
Hypersensitivity

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Effects of methyl p-hydroxybenzoate (methyl paraben) on Ca 2+ concentration and histamine release in rat peritoneal mast cells. / Fukugasako, Sanae; Ito, Shinichi; Ikemoto, Yoshimi.

In: British Journal of Pharmacology, Vol. 139, No. 2, 05.2003, p. 381-387.

Research output: Contribution to journalArticle

@article{1bb189fb20fa424d9b18ae6561ae9164,
title = "Effects of methyl p-hydroxybenzoate (methyl paraben) on Ca 2+ concentration and histamine release in rat peritoneal mast cells",
abstract = "1. Mechanisms of methyl p-hydroxybenzoate (methyl paraben) action in allergic reactions were investigated by measuring the intracellular Ca 2+ concentration ([Ca 2+] i) and histamine release in rat peritoneal mast cells (RPMCs). 2. In the presence or absence of extracellular Ca 2+, methyl paraben (0.1-10 mM) increased [Ca 2+] i, in a concentration-dependent manner. Under both the conditions, methyl paraben alone did not evoke histamine release. 3. In RPMCs pretreated with a protein kinase C (PKC) activator (phorbol 12-myristate 13-acetate (PMA) 3 and 10 nM), methyl paraben (0.3-3 mM) induced histamine release. However, a high concentration (10 mM) of the agent did not increase the histamine release. 4. U73122 (0.1 and 0.5 μM), an inhibitor of phospholipase C (PLC), significantly inhibited the methyl paraben-induced histamine release in PMA-pretreated RPMCs. U73343 (0.5 μM), an inactive analogue of U73122, did not inhibit the histamine release caused by methyl paraben. 5. In Ca 2+-free solution, PLC inhibitors (U73122 0.1 and 0.5 μM, D609 1-10 μM) inhibited the methyl paraben-induced increase in [Ca 2+] i, whereas U73343 (0.5 μM) did not. 6. Xestospongin C (2-20 μM) and 2 aminoethoxydiphenyl borate (30 and 100 μM), blockers of the inositol 1,4,5-trisphosphate (IP 3) receptor, inhibited the methyl paraben-induced increase in [Ca 2+] i in Ca 2+-free solution. 7. In conclusion, methyl paraben causes an increase in [Ca 2+] i, which may be due to release of Ca 2+ from storage sites by IP 3 via activation of PLC in RPMCs. In addition, methyl paraben possibly has some inhibitory effects on histamine release via unknown mechanisms.",
author = "Sanae Fukugasako and Shinichi Ito and Yoshimi Ikemoto",
year = "2003",
month = "5",
doi = "10.1038/sj.bjp.0705248",
language = "English",
volume = "139",
pages = "381--387",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Effects of methyl p-hydroxybenzoate (methyl paraben) on Ca 2+ concentration and histamine release in rat peritoneal mast cells

AU - Fukugasako, Sanae

AU - Ito, Shinichi

AU - Ikemoto, Yoshimi

PY - 2003/5

Y1 - 2003/5

N2 - 1. Mechanisms of methyl p-hydroxybenzoate (methyl paraben) action in allergic reactions were investigated by measuring the intracellular Ca 2+ concentration ([Ca 2+] i) and histamine release in rat peritoneal mast cells (RPMCs). 2. In the presence or absence of extracellular Ca 2+, methyl paraben (0.1-10 mM) increased [Ca 2+] i, in a concentration-dependent manner. Under both the conditions, methyl paraben alone did not evoke histamine release. 3. In RPMCs pretreated with a protein kinase C (PKC) activator (phorbol 12-myristate 13-acetate (PMA) 3 and 10 nM), methyl paraben (0.3-3 mM) induced histamine release. However, a high concentration (10 mM) of the agent did not increase the histamine release. 4. U73122 (0.1 and 0.5 μM), an inhibitor of phospholipase C (PLC), significantly inhibited the methyl paraben-induced histamine release in PMA-pretreated RPMCs. U73343 (0.5 μM), an inactive analogue of U73122, did not inhibit the histamine release caused by methyl paraben. 5. In Ca 2+-free solution, PLC inhibitors (U73122 0.1 and 0.5 μM, D609 1-10 μM) inhibited the methyl paraben-induced increase in [Ca 2+] i, whereas U73343 (0.5 μM) did not. 6. Xestospongin C (2-20 μM) and 2 aminoethoxydiphenyl borate (30 and 100 μM), blockers of the inositol 1,4,5-trisphosphate (IP 3) receptor, inhibited the methyl paraben-induced increase in [Ca 2+] i in Ca 2+-free solution. 7. In conclusion, methyl paraben causes an increase in [Ca 2+] i, which may be due to release of Ca 2+ from storage sites by IP 3 via activation of PLC in RPMCs. In addition, methyl paraben possibly has some inhibitory effects on histamine release via unknown mechanisms.

AB - 1. Mechanisms of methyl p-hydroxybenzoate (methyl paraben) action in allergic reactions were investigated by measuring the intracellular Ca 2+ concentration ([Ca 2+] i) and histamine release in rat peritoneal mast cells (RPMCs). 2. In the presence or absence of extracellular Ca 2+, methyl paraben (0.1-10 mM) increased [Ca 2+] i, in a concentration-dependent manner. Under both the conditions, methyl paraben alone did not evoke histamine release. 3. In RPMCs pretreated with a protein kinase C (PKC) activator (phorbol 12-myristate 13-acetate (PMA) 3 and 10 nM), methyl paraben (0.3-3 mM) induced histamine release. However, a high concentration (10 mM) of the agent did not increase the histamine release. 4. U73122 (0.1 and 0.5 μM), an inhibitor of phospholipase C (PLC), significantly inhibited the methyl paraben-induced histamine release in PMA-pretreated RPMCs. U73343 (0.5 μM), an inactive analogue of U73122, did not inhibit the histamine release caused by methyl paraben. 5. In Ca 2+-free solution, PLC inhibitors (U73122 0.1 and 0.5 μM, D609 1-10 μM) inhibited the methyl paraben-induced increase in [Ca 2+] i, whereas U73343 (0.5 μM) did not. 6. Xestospongin C (2-20 μM) and 2 aminoethoxydiphenyl borate (30 and 100 μM), blockers of the inositol 1,4,5-trisphosphate (IP 3) receptor, inhibited the methyl paraben-induced increase in [Ca 2+] i in Ca 2+-free solution. 7. In conclusion, methyl paraben causes an increase in [Ca 2+] i, which may be due to release of Ca 2+ from storage sites by IP 3 via activation of PLC in RPMCs. In addition, methyl paraben possibly has some inhibitory effects on histamine release via unknown mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=0037592640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037592640&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0705248

DO - 10.1038/sj.bjp.0705248

M3 - Article

VL - 139

SP - 381

EP - 387

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 2

ER -